Sentinel lymph node molecular pathology in breast carcinoma

Diagnostic Molecular Pathology

Volumn 17, Issue 4, 2008, Pages 214-219

  Denninghoff, Valeria ^a,b   Allende, Daniela ^a   Paesani, Fernando ^a   Garcia, Alejandro ^a   Avagnina, Alejandra ^a   Perazzo, Florencia ^a   Abalo, Eduardo ^a   Crimi, Gabriel ^a   Elsner, Boris ^a  

^a CEMIC   (Argentina)

^b NONE   (Argentina)

Author keywords

Breast cancer; Mammaglobin; PCR; Sentinel lymph node

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN; MAMMAGLOBIN; MESSENGER RNA;

ARTICLE; BREAST CARCINOMA; CLONE; CONTROLLED STUDY; CYTOLOGY; DILUTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROMETASTASIS; MOLECULAR BIOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE;

BASE SEQUENCE; BREAST NEOPLASMS; CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MOLECULAR SEQUENCE DATA; MYELIN PROTEINS; NEOPLASM PROTEINS; PROTEOLIPIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTEROGLOBIN;

EID: 57649120003     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e3181601777     Document Type: Article

References (32)

1. Ellis I, Schitt S, Sastre-Garau X, et al. World Health Organization of Tumours. Invasive Breast Carcinoma. Tumours of the Breast and Female Genital Organs. Pathology and Genetics. Lyon: IARC Press; 2003.
2. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24740 breast cancer cases. Cancer. 1989;63:181-187.
3. Fisher ER, Sass R, Fisher B. Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure. Cancer. 1984;53:712-723.
4. Wenche R, Per B, Berit S, et al. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up. Breast J. 2004;10:174-180.
5. Giuliano A, Haigh P, Brennan M, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000;18:2553-2559.
6. Bostick PJ, Morton DL, Turner RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol. 1999;17:3238-3244.
7. Shivers S, Wang X, Li W, et al. Molecular staging of malignant melanoma. Correlation with clinical outcome. JAMA. 1998;280:1410-1415.
8. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
9. Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg. 1991;214:637-641.
10. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. A multicenter validation study. NEJM. 1998;339:941-946.
11. Guillanders WE, Mikhitarian K, Hebert R, et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis. Ann Surg. 2004;239:828-840.
12. Ouellette RJ, Richard D, Maicas E. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes. Am J Clin Pathol. 2004;121:637-643.
13. Timar J, Csuka O, Orosz Z, et al. Molecular pathology of tumour metastasis. II. Molecular staging and differential diagnosis. Pathol Oncol Res. 2002;8:204-219.
14. Denninghoff V, Kahn A, Falco J, et al. Sentinel lymph node. Detection of micrometastases of melanoma in a molecular study. Mol Diagn. 2004;8:253-258.
15. Liberman L. Pathologic analysis of sentinel lymph nodes in breast carcinoma. Cancer. 2000;88:971-977.
16. Cummings M, Walsh M, Hohn B, et al. Occult axillary node metastases in breast cancer do matter: results of 10 year survival analysis. Am J Surg Pathol. 2002;26:1286-1295.
17. Dowlatshahi K, Fan M, Bloom K, et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer. 1999;86:990-996.
18. Ouellette J, Richard D, Maicas E. Correction of RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes. Am J Clin Pathol. 2004;122:813.
19. Watson M, Fleming T. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 1996;56:860-865.
20. Tanis P, Boom R, Koops H, et al. Frozen section investigation of sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol. 2001;8:222-226.
21. Yared M, Middleton L, Smith T, et al. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol. 2002;26:377-382.
22. Cserni G, Amendoeira I, Postolikas N, et al. Discrepancies in current practice of pathological evaluation of sentinel lymph node in breast cancer. Results of a questionnaire based survey by the European Working Group for breast screening pathology. J Clin Pathol. 2004;57:695-701.
23. Blaheta H, Schittek B, Breuninger H, et al. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to inmunohistochemistry. Int J Cancer. 1998;79:318-323.
24. Li Y, Chie S, Hsueh S, et al. Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients. Cancer Sci. 2003;94:99-102.
25. Freneaux P, Nos C, Vincent-Salomon A, et al. Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for sensitive methodology usable in daily practice. Mod Pathol. 2002;15:641-646.
26. Watson M, Dintzis S, Darrow C, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res. 1999;59:3028-3031.
27. Zehentner B, Persing D, Deme A, et al. Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription PCR assay and sandwich ELISA. Clin Chem. 2004;50:2069-2076.
28. Zach O, Lutz D. Mammaglobin remains a useful marker for the detection of breast cancer cells in peripheral blood. J Clin Oncol. 2005;23:3160-3161.
29. Mercatali L, Valenti V, Calistri D, et al. RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients. Ann Oncol. 2006;17:424-428.
30. Benoy IH, Van Der Auwera I, Van Laere S, et al. Real-time RT-PCR correlates with inmunocytochemistry for detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer. J Cancer. 2004;15:1813-1820.
31. Cerveira N, Torres L, Rocha P, et al. Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients. Int J Cancer. 2004;108:592-595.
32. Gimbergues P, Dauplat MM, Cayre A, et al. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category. Eur J Surg Oncol. 2007;33:16-22.